How to merge Roche and Genentech

Want a primer on the legal ins and outs of Roche's bid for Genentech? We don't blame you. Between state and federal laws and the two companies' own affiliation agreement, the deal could get pretty complicated. Luckily, DealBook has obliged. Report

Suggested Articles

AstraZeneca
Marketing

AZ's Calquence steps up to challenge Imbruvica with big CLL nod

Imbruvica has enjoyed a nice run in previously untreated CLL over the last few years. But major competition is here in the form of AZ's Calquence.

by Carly Helfand, by Angus Liu
jnj
Pharma

J&J's Risperdal caseload explodes with Pennsylvania ruling

Pennsylvania's Supreme Court revived thousands of lawsuits alleging the antipsychotic med Risperdal caused males to develop breasts.

by Eric Sagonowsky
Black-and-white image of a thumbs-up hand and a thumbs-down hand in front of a blank wall.
Marketing

Which asthma biologic is the most popular of them all?

In the asthma biologics race, there doesn't appear to be a clear favorite among Xolair, Dupixent, Fasenra and Nucala for a group of pulmonologists.

by Angus Liu